Financials
- Market Capitalization 511.89 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.31
市销率
1.44
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2714 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 3.76 USD | -1.57% | +3.30% | -8.29% | +154.05% | 621.30 M USD | ||
| 2732 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.81 USD | +0.63% | +4.11% | +2.34% | -27.78% | 603.71 M USD | ||
| 2854 | TLRY Tilray Brands, Inc. - Common Stock | 3.36 USD | -5.08% | -10.16% | -15.79% | +104.88% | 496.57 M USD | ||
| 2875 | EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.37 USD | -10.46% | -20.81% | -18.45% | -67.92% | 487.11 M USD |